Memorial Sloan Kettering Hematologic Oncologist Eytan Stein

Areas of Expertise

Conditions I Treat

  • Leukemia
  • Acute lymphocytic leukemia (ALL)
  • Acute myeloid leukemia (AML)

My Specialties

  • Early drug development
  • Clinical trials
  • Early-phase clinical trials
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

I am a hematologist-oncologist who specializes in caring for people with acute and chronic leukemias, myelodysplastic syndromes, and myeloproliferative neoplasms. I am dedicated to providing my patients with the best care tailored to their unique situation. To do this, we work together to develop a personalized treatment plan that takes into account their needs as well as their family’s.

I am also an active clinical researcher who develops new and innovative approaches to treating acute myeloid leukemia (AML).

I am the principal investigator on a wide variety of clinical trials for people with AML. I am working to develop new therapies — such as small molecule inhibitors — that can more precisely and effectively target AML. My goal as a doctor and researcher is to help people with AML and other blood cancers have the best possible outcomes.

What I Do at MSK

I’m a leukemia specialist, which is a doctor with special training in diagnosing and treating leukemia (loo-KEE-mee-uh). This cancer starts in tissue that forms blood, such as bone marrow.

I'm an early drug development specialist, which is a scientist who tests new drugs to treat cancer. I have special training in research studies, also known as clinical trials.

  • Chief, Leukemia Service
  • Director, Program for Drug Development in Leukemia, Division of Hematologic Malignancies
Areas of Expertise

Conditions I Treat

  • Leukemia
  • Acute lymphocytic leukemia (ALL)
  • Acute myeloid leukemia (AML)
  • Acute promyelocytic leukemia (APL)
  • Chronic lymphocytic leukemia (CLL)
  • Chronic myeloid leukemia (CML)
  • Myeloproliferative neoplasms (MPN)/Myeloproliferative disorders
  • Myelodysplastic syndrome (MDS)
  • Hairy cell leukemia (HCL)
  • Systemic mastocytosis
  • Blood, bone marrow, and hematologic cancers and conditions

My Specialties

  • Early drug development
  • Clinical trials
  • Early-phase clinical trials
  • Targeted therapy
Education & Honors

Education

  • MD, Northwestern University Medical School

Residencies

  • Northwestern Memorial Hospital

Fellowships

  • Memorial Sloan Kettering Cancer Center

Board Certifications

  • Internal Medicine
  • Medical Oncology
  • Hematology

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Current Patients
Request an appointment by calling your Care Team or messaging them in MSK MyChart.

Contact and Location

Office Phone
Location
New York, NY

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Leukemia Service doctors

See all Collaborators doctors

See all Early Drug Development Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Stein’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Eytan M. Stein discloses the following relationships and financial interests:

  • AbbVie
    Professional Services and Activities
  • Agios Pharmaceuticals
    Professional Services and Activities
  • AstraZeneca
    Professional Services and Activities
  • Auron Therapeutics, Inc.
    Equity
  • Bristol-Myers Squibb
    Professional Services and Activities
  • Celgene
    Professional Services and Activities
  • Daiichi Sankyo
    Professional Services and Activities
  • Genentech
    Professional Services and Activities
  • Janssen Global Services, LLC
    Professional Services and Activities
  • Kyowa Kirin Co., Ltd
    Professional Services and Activities
  • Scaffold Therapeutics, Inc.
    Equity
  • Servier
    Professional Services and Activities
  • Treeline Biosciences, Inc.
    Equity
  • Trio Pharmaceuticals, Inc.
    Equity

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures